Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

The preneoplastic phenotype in murine mammary tumorigenesis.

Medina D.

J Mammary Gland Biol Neoplasia. 2000 Oct;5(4):393-407. Review.

PMID:
14973384
2.

Biological and molecular characteristics of the premalignant mouse mammary gland.

Medina D.

Biochim Biophys Acta. 2002 Oct 2;1603(1):1-9. Review.

PMID:
12242106
3.

Premalignant and malignant mammary lesions induced by MMTV and chemical carcinogens.

Medina D.

J Mammary Gland Biol Neoplasia. 2008 Sep;13(3):271-7. doi: 10.1007/s10911-008-9086-4. Epub 2008 Jul 29. Review.

PMID:
18663563
4.

Preneoplastic lesions in murine mammary cancer.

Medina D.

Cancer Res. 1976 Jul;36(7 PT 2):2589-95.

5.

Mammary gland as a morphological end point in carcinogenesis studies.

Medina D.

J Toxicol Environ Health. 1976 Mar;1(4):551-60.

PMID:
177787
6.

Biological and genetic properties of the p53 null preneoplastic mammary epithelium.

Medina D, Kittrell FS, Shepard A, Stephens LC, Jiang C, Lu J, Allred DC, McCarthy M, Ullrich RL.

FASEB J. 2002 Jun;16(8):881-3. Epub 2002 Apr 10.

PMID:
11967232
7.

Histological and immunohistochemical identification of atypical ductal mammary hyperplasia as a preneoplastic marker in dogs.

Ferreira E, Gobbi H, Saraiva BS, Cassali GD.

Vet Pathol. 2012 Mar;49(2):322-9. doi: 10.1177/0300985810396105. Epub 2011 Jan 31.

PMID:
21282668
8.

Multistep mouse mammary tumorigenesis through pre-neoplasia to neoplasia and acquisition of metastatic potential.

Tsubura A, Yoshizawa K, Uehara N, Yuri T, Matsuoka Y.

Med Mol Morphol. 2007 Mar;40(1):9-17. Epub 2007 Mar 29. Review.

PMID:
17384984
9.
10.
11.

Human Cripto-1 overexpression in the mouse mammary gland results in the development of hyperplasia and adenocarcinoma.

Wechselberger C, Strizzi L, Kenney N, Hirota M, Sun Y, Ebert A, Orozco O, Bianco C, Khan NI, Wallace-Jones B, Normanno N, Adkins H, Sanicola M, Salomon DS.

Oncogene. 2005 Jun 9;24(25):4094-105.

PMID:
15897912
12.

Mutations in p53 are frequent in the preneoplastic stage of mouse mammary tumor development.

Jerry DJ, Ozbun MA, Kittrell FS, Lane DP, Medina D, Butel JS.

Cancer Res. 1993 Jul 15;53(14):3374-81.

13.

Hyperplasia and impaired involution in the mammary gland of transgenic mice expressing human FGF4.

Morini M, Astigiano S, Mora M, Ricotta C, Ferrari N, Mantero S, Levi G, Rossini M, Barbieri O.

Oncogene. 2000 Dec 7;19(52):6007-14.

14.

Transgenic Polyoma middle-T mice model premalignant mammary disease.

Maglione JE, Moghanaki D, Young LJ, Manner CK, Ellies LG, Joseph SO, Nicholson B, Cardiff RD, MacLeod CL.

Cancer Res. 2001 Nov 15;61(22):8298-305.

15.

Characterization of mammary plaques in DDD mice congenic for Mtv-2 gene, DDD/1-Mtv-2/Mtv-2.

Matsuzawa A, Kaneko T, Takeda Y, Murakami A, Tsubura A.

Jpn J Cancer Res. 1993 Jan;84(1):48-54.

PMID:
8383648
16.
17.

Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability.

McCormack SJ, Weaver Z, Deming S, Natarajan G, Torri J, Johnson MD, Liyanage M, Ried T, Dickson RB.

Oncogene. 1998 May 28;16(21):2755-66.

18.

Protoneoplasia: the molecular biology of murine mammary hyperplasia.

Cardiff RD.

Adv Cancer Res. 1984;42:167-90. Review.

PMID:
6098147
20.

Activation of phosphatidylinositol 3-kinase by membrane localization of p110alpha predisposes mammary glands to neoplastic transformation.

Renner O, Blanco-Aparicio C, Grassow M, CaƱamero M, Leal JF, Carnero A.

Cancer Res. 2008 Dec 1;68(23):9643-53. doi: 10.1158/0008-5472.CAN-08-1539.

Supplemental Content

Support Center